These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15966405)

  • 1. [Molecular targeting therapy for leukemia by sphingolipid ceramide].
    Okazaki T
    Rinsho Byori; 2005 May; 53(5):413-21. PubMed ID: 15966405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
    Itoh M; Kitano T; Watanabe M; Kondo T; Yabu T; Taguchi Y; Iwai K; Tashima M; Uchiyama T; Okazaki T
    Clin Cancer Res; 2003 Jan; 9(1):415-23. PubMed ID: 12538495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
    Furlong SJ; Ridgway ND; Hoskin DW
    Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Turzanski J; Grundy M; Shang S; Russell N; Pallis M
    Exp Hematol; 2005 Jan; 33(1):62-72. PubMed ID: 15661399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity.
    Tserng KY; Griffin RL
    Biochem J; 2004 Jun; 380(Pt 3):715-22. PubMed ID: 14998372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sphingolipid-mediated apoptotic signaling pathways].
    Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
    J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
    Huwiler A; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of de novo synthetic pathway of ceramides is responsible for the initiation of hydrogen peroxide-induced apoptosis in HL-60 cells.
    Son JH; Yoo HH; Kim DH
    J Toxicol Environ Health A; 2007 Aug; 70(15-16):1310-8. PubMed ID: 17654249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis occurs via the ceramide recycling pathway in human HaCaT keratinocytes.
    Takeda S; Mitsutake S; Tsuji K; Igarashi Y
    J Biochem; 2006 Feb; 139(2):255-62. PubMed ID: 16452313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of sphingolipids in apoptin-induced cell killing.
    Liu X; Zeidan YH; Elojeimy S; Holman DH; El-Zawahry AM; Guo GW; Bielawska A; Bielawski J; Szulc Z; Rubinchik S; Dong JY; Keane TE; Tavassoli M; Hannun YA; Norris JS
    Mol Ther; 2006 Nov; 14(5):627-36. PubMed ID: 16926120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide: an intracellular mediator of apoptosis and growth suppression.
    Saba JD; Obeid LM; Hannun YA
    Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):233-40; discussion 240-1. PubMed ID: 8650271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic death by ceramide: will the real killer please stand up?
    Radin NS
    Med Hypotheses; 2001 Jul; 57(1):96-100. PubMed ID: 11421634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of C16 ceramide accumulation during apoptosis in prostate cancer cells.
    Eto M; Bennouna J; Hunter OC; Lotze MT; Amoscato AA
    Int J Urol; 2006 Feb; 13(2):148-56. PubMed ID: 16563140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells.
    Sanvicens N; Cotter TG
    J Neurochem; 2006 Sep; 98(5):1432-44. PubMed ID: 16923157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sphingolipid and apoptosis].
    Wang J; Hu XS; Shi JP
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.
    Herrera B; Carracedo A; Diez-Zaera M; Gómez del Pulgar T; Guzmán M; Velasco G
    Exp Cell Res; 2006 Jul; 312(11):2121-31. PubMed ID: 16624285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKB/Akt inhibits ceramide-induced apoptosis in neuroblastoma cells by blocking apoptosis-inducing factor (AIF) translocation.
    Kim NH; Kim K; Park WS; Son HS; Bae Y
    J Cell Biochem; 2007 Dec; 102(5):1160-70. PubMed ID: 17471535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.